Milan, November 03, 2017. Europe POCT Market to reach almost USD 12 billion by 2024 – Emerging Microfluidic Lab-on-a-Chip Technology.

[et_pb_section bb_built=”1″ background_color=”#ffffff” _builder_version=”3.0.92″ background_image=”” parallax=”on” animation_style=”slide” animation_direction=”left” animation_duration=”550ms” animation_intensity_slide=”5%” box_shadow_style=”preset3″ box_shadow_vertical=”23px” box_shadow_blur=”30px” box_shadow_spread=”-11px” box_shadow_color=”rgba(145,145,145,0.3)”][et_pb_row _builder_version=”3.0.92″ background_size=”initial” background_position=”top_left” background_repeat=”repeat”][et_pb_column type=”4_4″][et_pb_text _builder_version=”3.5″ background_size=”initial” background_position=”top_left” background_repeat=”repeat”]

dianax miniaturized microfluidics-based lab-on-a-chip will bring laboratory testing to the patient’s fingertips including HbA1c and CRP. According to Data Bridge Market Research, the Europe Point-of-Care Testing (POCT) devices market is expected to reach USD 11,682.54 billion by 2024 from USD 6,051.05 billion in 2016, at a CAGR of 8.6% in the forecast period 2017 to 2024. The major factors driving the growth of this market are the increasing incidence of chronic diseases, rising demand for self-testing point-of-care testing devices, decentralized laboratory testing, and technological advancements like microfluidic lab on a chip technology. These factors increase the demand for devices such as blood glucose meter, HBA1C, CRP… More info at

[/et_pb_text][et_pb_image src=”” _builder_version=”3.5″]